LTS White Paper

WHITE PAPER

LTS White PaperLTS White Paper

WHITE PAPER

Incisive thought leadership on non-invasive drug delivery

Our expertise and experience in a range of therapy areas and delivery technologies is shared in technical white papers, both from scientific and commercial perspectives.
  • home-based palliative care
    March 15, 2023

    Innovation in drug delivery to transform home-based palliative care

    read more
  • The CEO of LTS
    January 29, 2023

    The CEO Perspective: Stick to your strategy in turbulent times

    read more
  • Dr Frank Theobald, Head of MAP-Program at LTS
    October 17, 2022

    Microarray patches show new promise on path to patient-centric medicine

    read more
  • September 7, 2022

    Interview with Dr. Mike Schaefers, Chief Commercial Officer at LTS

    read more
  • LTS Lohmann: S Ketamine OTF
    August 10, 2022

    S-ketamine oral thin film – population pharmacokinetics and pharmacodynamics of S-ketamine, S-norketamine and S-hydroxynorketamine

    read more
  • LTS: In vitro to in vivo:
    July 4, 2022

    In vitro to in vivo: De-risking the critical path from laboratory to clinical trial for transdermal therapies

    read more